Compare commits
1 commit
904f0ceec1
...
766bef0403
| Author | SHA1 | Date | |
|---|---|---|---|
|
|
766bef0403 |
6 changed files with 120 additions and 1 deletions
|
|
@ -17,6 +17,12 @@ The closed-loop referral platforms (Unite Us with 60 million connections, Findhe
|
|||
|
||||
The near-term trajectory: mandatory outpatient screening by 2026, Z-code adoption rising to 15-25% by 2028, closed-loop referral integration in major EHRs by 2030, and SDOH interventions as standard as medication management by 2035. The binding constraint is not evidence or policy but operational infrastructure.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2024-09-19-commonwealth-fund-mirror-mirror-2024]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
|
||||
|
||||
The Commonwealth Fund 2024 international comparison provides macro-level evidence for why SDOH infrastructure matters. The US ranks second in care process (clinical quality) but last in outcomes, with worst performance in access and equity domains. This gap—excellent clinical care, worst population outcomes—is the international proof that non-clinical factors (social determinants, access, equity) are the binding constraint on US health outcomes. The US has the clinical capability but lacks the operational infrastructure to address the structural determinants that drive outcomes. This makes the case for SDOH infrastructure not just an ROI argument but a systems-level necessity to close the care process vs. outcomes gap, extending the claim from cost-benefit to structural imperative.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -29,6 +29,12 @@ The claim that "90% of health outcomes are determined by non-clinical factors" h
|
|||
|
||||
This has structural implications for how healthcare should be organized. Since [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]], the 90% finding argues that the 86% of payments still not at full risk are systematically ignoring the factors that matter most. Fee-for-service reimburses procedures, not outcomes, creating no incentive to address food insecurity, social isolation, or housing instability -- even though these may matter more than the procedure itself.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-09-19-commonwealth-fund-mirror-mirror-2024]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
|
||||
|
||||
The Commonwealth Fund's 2024 Mirror Mirror international comparison provides the strongest international evidence for this claim. The US ranks **second in care process** (clinical quality when care is accessed) but **last in health outcomes** (shortest life expectancy, most avoidable deaths) among 10 peer nations (Australia, Canada, France, Germany, Netherlands, New Zealand, Sweden, Switzerland, UK, US). This paradox—near-best clinical care producing worst population outcomes—proves that clinical excellence alone does not determine health outcomes. The binding constraints are structural: access (US among worst), equity (US second-worst), and the social determinants the system does not address. The US has the clinical capability but lacks the structural conditions to convert that capability into population health, confirming that non-clinical factors dominate outcomes.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -25,6 +25,12 @@ This creates a profound paradox for economic development: a society can be absol
|
|||
|
||||
Since specialization and value form an autocatalytic feedback loop where each amplifies the other exponentially, the same specialization that drives economic growth also drives the inequality that undermines health. Since healthcare costs threaten to crowd out investment in humanitys future if the system is not restructured, the epidemiological transition explains WHY healthcare costs escalate: the system is fighting psychosocially-driven disease with materialist medicine.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-09-19-commonwealth-fund-mirror-mirror-2024]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
|
||||
|
||||
The Commonwealth Fund 2024 international comparison provides direct evidence for this claim. Among 10 high-income countries, the US—despite highest spending (>16% GDP) and second-best clinical care quality—ranks last in health outcomes and second-worst in equity. The top performers (Australia, Netherlands) have the lowest spending as % of GDP. This confirms that in developed nations, health outcomes are determined by structural factors (access, equity, social determinants) rather than clinical capability or resource availability. The US has eliminated material scarcity in healthcare (highest spending, best clinical care) but ranks worst because social disadvantage (access barriers, discrimination, income-based treatment gaps) dominates outcomes, directly supporting the epidemiological transition thesis.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -0,0 +1,47 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: "Commonwealth Fund 2024 international comparison shows US clinical care quality is near-best while population outcomes are worst among 10 peer nations, proving the system's failure is structural not clinical"
|
||||
confidence: proven
|
||||
source: "Commonwealth Fund Mirror Mirror 2024 (Blumenthal et al), 70-measure comparison across 10 high-income countries"
|
||||
created: 2026-03-11
|
||||
---
|
||||
|
||||
# US healthcare ranks second in care process but last in outcomes proving structural failure not clinical quality deficit
|
||||
|
||||
The Commonwealth Fund's 2024 Mirror Mirror report compared 10 high-income countries across 70 measures in 5 performance domains. The United States ranked **second in care process** (clinical quality when care is accessed) but **last overall** and **last in health outcomes** (shortest life expectancy, most avoidable deaths).
|
||||
|
||||
This paradox is definitive evidence that the US healthcare system's failure is structural—access, equity, and system design—not a deficit in clinical capability. The care delivered inside US clinics is among the world's best. The problem is who gets in and at what cost.
|
||||
|
||||
## Evidence
|
||||
|
||||
**Rankings by domain (10 countries: Australia, Canada, France, Germany, Netherlands, New Zealand, Sweden, Switzerland, UK, US):**
|
||||
- **Overall:** US ranked 10th (last)
|
||||
- **Care Process:** US ranked 2nd
|
||||
- **Health Outcomes:** US ranked 10th (last) — shortest life expectancy, most avoidable deaths
|
||||
- **Access to Care:** US among worst — low-income Americans much more likely to experience access problems
|
||||
- **Equity:** US ranked 9th (second-worst, only New Zealand worse) — highest rates of unfair treatment, discrimination, concerns not taken seriously due to race/ethnicity
|
||||
- **Efficiency:** US among worst — highest spending, lowest return
|
||||
|
||||
**Spending paradox:**
|
||||
- US spends >16% of GDP on healthcare (2022)
|
||||
- Top two overall performers (Australia, Netherlands) have the **lowest** spending as % of GDP
|
||||
- US achieves near-best care process scores but worst outcomes and access
|
||||
|
||||
**Methodology:**
|
||||
- 70 unique measures across 5 performance domains
|
||||
- Nearly 75% of measures from patient or physician reports
|
||||
- Consistent US last-place ranking across multiple editions of Mirror Mirror
|
||||
|
||||
**Why this proves structural failure, not clinical deficit:**
|
||||
The US has the clinical capability to deliver world-class care (ranked 2nd in care process) but ranks last in outcomes because the structural barriers—access (worst among peers), equity (second-worst), and fragmentation—prevent that capability from reaching populations that need it. Clinical excellence inside the clinic cannot produce population health when access and equity failures are severe. This is the strongest international evidence that clinical quality alone does not determine outcomes.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
|
||||
- [[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]
|
||||
- [[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]]
|
||||
|
||||
Topics:
|
||||
- [[domains/health/_map]]
|
||||
|
|
@ -0,0 +1,39 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: "US spends over 16% of GDP on healthcare while top performers Australia and Netherlands spend the least, proving spending level does not determine outcomes"
|
||||
confidence: proven
|
||||
source: "Commonwealth Fund Mirror Mirror 2024, international comparison of 10 high-income countries"
|
||||
created: 2026-03-11
|
||||
---
|
||||
|
||||
# US healthcare spending is highest among peer nations at 16 percent GDP while achieving worst outcomes
|
||||
|
||||
The United States spends over 16% of GDP on healthcare (2022), the highest among 10 peer nations in the Commonwealth Fund's 2024 Mirror Mirror comparison. Despite this spending outlier status, the US ranked last overall and last in health outcomes (shortest life expectancy, most avoidable deaths).
|
||||
|
||||
The top two overall performers—Australia and Netherlands—have the **lowest** healthcare spending as a percentage of GDP among the comparison countries. This proves that spending level does not determine outcomes and that the US system's problem is efficiency and structural design, not resource scarcity.
|
||||
|
||||
## Evidence
|
||||
|
||||
**Spending vs. outcomes paradox:**
|
||||
- US: >16% of GDP (2022), ranked 10th overall, 10th in outcomes
|
||||
- Australia: lowest spending % of GDP, ranked 1st overall
|
||||
- Netherlands: lowest spending % of GDP, ranked 2nd overall
|
||||
|
||||
**Performance domains:**
|
||||
- US ranked among worst in access, equity, efficiency, and outcomes
|
||||
- US ranked 2nd in care process (clinical quality when accessed)
|
||||
- Highest spending + worst outcomes = structural inefficiency, not clinical capability deficit
|
||||
|
||||
**Why this matters:**
|
||||
The US does not have a resource problem—it has an allocation and access problem. The system spends more than any peer nation but fails to convert that spending into population health because the structural barriers (access, equity, fragmentation) prevent the clinical capability from reaching those who need it. The inverse relationship between spending and outcomes among peer nations proves that more money does not solve healthcare system failure when the underlying structure is broken.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
|
||||
- [[the healthcare cost curve bends up through 2035 because new curative and screening capabilities create more treatable conditions faster than prices decline]]
|
||||
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
|
||||
|
||||
Topics:
|
||||
- [[domains/health/_map]]
|
||||
|
|
@ -7,9 +7,15 @@ date: 2024-09-19
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: report
|
||||
status: unprocessed
|
||||
status: processed
|
||||
priority: high
|
||||
tags: [international-comparison, commonwealth-fund, health-outcomes, access, equity, efficiency, mirror-mirror]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-11
|
||||
claims_extracted: ["us-healthcare-ranks-second-in-care-process-but-last-in-outcomes-proving-structural-failure-not-clinical-quality-deficit.md", "us-healthcare-spending-is-highest-among-peer-nations-at-16-percent-gdp-while-achieving-worst-outcomes.md"]
|
||||
enrichments_applied: ["medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md", "the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations.md", "SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "Extracted the core paradox claim (care process vs. outcomes) and the spending outlier claim. Both are proven confidence level due to rigorous 70-measure methodology across 10 countries. Enriched three existing claims with international evidence confirming that clinical quality does not determine population health outcomes when structural barriers (access, equity, SDOH) are present. This is the definitive international benchmark for US healthcare's structural failure and the strongest evidence supporting the 10-20% medical care contribution to outcomes claim."
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -62,3 +68,12 @@ The US system delivers excellent clinical care to those who access it, but the a
|
|||
PRIMARY CONNECTION: [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
|
||||
WHY ARCHIVED: The strongest international evidence supporting Belief 2. First international comparison source in the KB.
|
||||
EXTRACTION HINT: The paradox — 2nd in care process, last in outcomes — is the single most extractable insight. It's the international proof that US healthcare's problem is structural, not clinical.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Commonwealth Fund Mirror Mirror 2024 compared 10 countries: Australia, Canada, France, Germany, Netherlands, New Zealand, Sweden, Switzerland, UK, US
|
||||
- Overall rankings: 1. Australia, 2. Netherlands, 3. UK, 4. New Zealand, 5. France, 10. US (last)
|
||||
- US ranked 2nd in care process, 10th (last) in health outcomes, 9th in equity, among worst in access and efficiency
|
||||
- US spends >16% of GDP on healthcare (2022), highest among peer nations
|
||||
- Top performers Australia and Netherlands have lowest spending as % of GDP
|
||||
- 70 unique measures across 5 performance domains, nearly 75% from patient or physician reports
|
||||
|
|
|
|||
Loading…
Reference in a new issue